Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain.

Ross JP, Lockett LJ, Tabor B, Saunders IW, Young GP, Macrae F, Blanco I, Capella G, Brown GS, Lockett TJ, Hannan GN.

BMC Cancer. 2014 Jul 1;14:475. doi: 10.1186/1471-2407-14-475.

PMID:
24981199
[PubMed - in process]
Free PMC Article
2.

A panel of genes methylated with high frequency in colorectal cancer.

Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, Duesing KR, Buckley MJ, Dunne R, Beetson I, Rand KN, McEvoy A, Thomas ML, Baker RT, Wattchow DA, Young GP, Lockett TJ, Pedersen SK, Lapointe LC, Molloy PL.

BMC Cancer. 2014 Jan 31;14:54. doi: 10.1186/1471-2407-14-54.

PMID:
24485021
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Repair and removal of azoxymethane-induced O6-methylguanine in rat colon by O6-methylguanine DNA methyltransferase and apoptosis.

Nyskohus LS, Watson AJ, Margison GP, Le Leu RK, Kim SW, Lockett TJ, Head RJ, Young GP, Hu Y.

Mutat Res. 2013 Dec 12;758(1-2):80-6. doi: 10.1016/j.mrgentox.2013.10.001. Epub 2013 Oct 16.

PMID:
24140386
[PubMed - indexed for MEDLINE]
4.

Crohn’s disease: towards improving postsurgical outcomes.

Lockett TJ, Kamm MA, De Cruz P, Kirkwood CD.

Med J Aust. 2013 Oct 21;199(8):524. No abstract available.

PMID:
24138368
[PubMed - indexed for MEDLINE]
5.

Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells.

Fung KY, Ooi CC, Lewanowitsch T, Tan S, Tan HT, Lim TK, Lin Q, Williams DB, Lockett TJ, Cosgrove LJ, Chung MC, Head RJ.

J Proteome Res. 2012 Dec 7;11(12):6019-29. doi: 10.1021/pr3007107. Epub 2012 Nov 5.

PMID:
23057685
[PubMed - indexed for MEDLINE]
6.

Resistant starches protect against colonic DNA damage and alter microbiota and gene expression in rats fed a Western diet.

Conlon MA, Kerr CA, McSweeney CS, Dunne RA, Shaw JM, Kang S, Bird AR, Morell MK, Lockett TJ, Molloy PL, Regina A, Toden S, Clarke JM, Topping DL.

J Nutr. 2012 May;142(5):832-40. doi: 10.3945/jn.111.147660. Epub 2012 Mar 28.

PMID:
22457395
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats.

Clarke JM, Young GP, Topping DL, Bird AR, Cobiac L, Scherer BL, Winkler JG, Lockett TJ.

Carcinogenesis. 2012 Jan;33(1):197-202. doi: 10.1093/carcin/bgr254. Epub 2011 Nov 10.

PMID:
22080572
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Is the tissue persistence of O(6)-methyl-2'-deoxyguanosine an indicator of tumour formation in the gastrointestinal tract?

Tan SL, Gerber JP, Cosgrove LJ, Lockett TJ, Clarke JM, Williams DB, Head RJ.

Mutat Res. 2011 Apr 3;721(2):119-26. doi: 10.1016/j.mrgentox.2010.12.016. Epub 2011 Feb 2.

PMID:
21295156
[PubMed - indexed for MEDLINE]
9.

Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.

Ooi CC, Good NM, Williams DB, Lewanowitsch T, Cosgrove LJ, Lockett TJ, Head RJ.

Clin Exp Pharmacol Physiol. 2010 Sep;37(9):905-11. doi: 10.1111/j.1440-1681.2010.05403.x. Epub 2010 May 24.

PMID:
20497425
[PubMed - indexed for MEDLINE]
10.

Efficacy of butyrate analogues in HT-29 cancer cells.

Ooi CC, Good NM, Williams DB, Lewanowitsch T, Cosgrove LJ, Lockett TJ, Head RJ.

Clin Exp Pharmacol Physiol. 2010 Apr;37(4):482-9. doi: 10.1111/j.1440-1681.2009.05335.x. Epub 2009 Nov 23.

PMID:
19930426
[PubMed - indexed for MEDLINE]
11.

Redesigned and chemically-modified hammerhead ribozymes with improved activity and serum stability.

Hendry P, McCall MJ, Stewart TS, Lockett TJ.

BMC Chem Biol. 2004 Dec 9;4(1):1.

PMID:
15588292
[PubMed - as supplied by publisher]
Free PMC Article
12.

Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.

Wang XY, Martiniello-Wilks R, Shaw JM, Ho T, Coulston N, Cooke-Yarborough C, Molloy PL, Cameron F, Moghaddam M, Lockett TJ, Webster LK, Smith IK, Both GW, Russell PJ.

Gene Ther. 2004 Nov;11(21):1559-67.

PMID:
15343359
[PubMed - indexed for MEDLINE]
13.

Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers.

Mir AA, Lockett TJ, Hendry P.

Nucleic Acids Res. 2001 May 1;29(9):1906-14.

PMID:
11328874
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Small, efficient hammerhead ribozymes.

McCall MJ, Hendry P, Mir AA, Conaty J, Brown G, Lockett TJ.

Mol Biotechnol. 2000 Jan;14(1):5-17.

PMID:
10911611
[PubMed - indexed for MEDLINE]
15.

A transfection compound series based on a versatile Tris linkage.

Cameron FH, Moghaddam MJ, Bender VJ, Whittaker RG, Mott M, Lockett TJ.

Biochim Biophys Acta. 1999 Feb 4;1417(1):37-50.

PMID:
10076034
[PubMed - indexed for MEDLINE]
Free Article
16.

A minimised hammerhead ribozyme with activity against interleukin-2 in human cells.

Sioud M, Opstad A, Hendry P, Lockett TJ, Jennings PA, McCall MJ.

Biochem Biophys Res Commun. 1997 Feb 13;231(2):397-402.

PMID:
9070287
[PubMed - indexed for MEDLINE]
17.

Design of hybridizing arms in hammerhead ribozymes.

Hendry P, McCall MJ, Lockett TJ.

Methods Mol Biol. 1997;74:253-64. No abstract available.

PMID:
9204440
[PubMed - indexed for MEDLINE]
18.

Defining optimum reaction conditions for hammerhead ribozymes.

Hendry P, McCall MJ, Lockett TJ.

Methods Mol Biol. 1997;74:231-9. No abstract available.

PMID:
9204438
[PubMed - indexed for MEDLINE]
19.

Characterizing ribozyme cleavage reactions.

Hendry P, McCall MJ, Lockett TJ.

Methods Mol Biol. 1997;74:221-9. No abstract available.

PMID:
9204437
[PubMed - indexed for MEDLINE]
20.

Minimized hammerhead ribozymes.

McCall MJ, Hendry P, Lockett TJ.

Methods Mol Biol. 1997;74:151-9. No abstract available.

PMID:
9204430
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk